Population pharmacokinetics and dose optimization of mycophenolic acid in HCT recipients receiving oral mycophenolate mofetil.
about
Pharmacokinetic and pharmacodynamic analysis of inosine monophosphate dehydrogenase activity in hematopoietic cell transplantation recipients treated with mycophenolate mofetil.Recipient pretransplant inosine monophosphate dehydrogenase activity in nonmyeloablative hematopoietic cell transplantationPopulation pharmacokinetic-pharmacodynamic modelling of mycophenolic acid in paediatric renal transplant recipients in the early post-transplant periodIntensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation.Higher Dose of Mycophenolate Mofetil Reduces Acute Graft-versus-Host Disease in Reduced-Intensity Conditioning Double Umbilical Cord Blood Transplantation.Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.Pharmacokinetics, Pharmacodynamics and Pharmacogenomics of Immunosuppressants in Allogeneic Haematopoietic Cell Transplantation: Part INonrelapse mortality and mycophenolic acid exposure in nonmyeloablative hematopoietic cell transplantationHigh prevalence of potential drug interactions affecting mycophenolic acid pharmacokinetics in nonmyeloablative hematopoietic stem cell transplant recipients.A pilot pharmacologic biomarker study in HLA-haploidentical hematopoietic cell transplant recipients.How accurate and precise are limited sampling strategies in estimating exposure to mycophenolic acid in people with autoimmune disease?Optimizing drug therapy in pediatric SCT: focus on pharmacokinetics.Clinical Pharmacokinetics of Mycophenolic Acid in Hematopoietic Stem Cell Transplantation Recipients.Haploidentical transplantation in children with unmanipulated peripheral blood stem cell graft: The need to look beyond post-transplantation cyclophosphamide in younger children.How I treat hepatitis C virus infection in patients with hematologic malignancies.Mycophenolate mofetil for treatment of steroid-refractory acute graft-versus-host disease after pediatric hematopoietic stem cell transplantation.Population pharmacokinetics and pharmacodynamics of mycophenolic acid using the prospective data in patients undergoing hematopoietic stem cell transplantation.Dosage Optimization of Nemolizumab Using Population Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Modeling and Simulation.Pharmacokinetic Variability of Mycophenolic Acid in Pediatric and Adult Patients With Hematopoietic Stem Cell Transplantation.
P2860
Q33905541-6EB6A0CF-783E-4145-9F2C-2507BAB177A4Q34175259-B455DD40-253D-4F39-B7FD-D3D5989DACF5Q34570937-91ACAE6F-2936-4792-9CA5-8FDE99970688Q35533371-5C246BAC-003B-49A8-9335-086A7C3FDBB5Q36623408-EE837B38-F63E-4F8F-A852-DFF8EC7FDD34Q36777485-23EEA9A7-4A00-47D0-9475-0D4B0B7AD581Q36777599-A1DEDAE8-C607-4F49-AF95-7A38191CAF9CQ37038889-07B9611A-152F-4C92-81FF-B0717CD49B87Q37135382-0AE12DE1-22CA-4D31-93F8-295FEE11D099Q37206443-4A757293-C119-4E49-8ECD-9EF9C2E9347DQ38170321-8D2A391E-0DD3-4903-B1B6-FC26A7FBD79DQ38262916-DE3DE08D-9154-4B4A-B9F3-454EB4C637C9Q38817096-13E407B9-3DBC-4175-874E-3E414AA2005EQ39741420-DF880CC6-7E75-48B4-ADD4-E78A81B83308Q40604797-F20A49F5-65B7-4403-B385-7F85C8BA736EQ41144188-14EEFA6F-B456-4A70-83D1-E7007AA7B55CQ47678205-57FA37B7-D019-42E8-A17C-18203B7A15D2Q48722683-4A4D2798-8459-4276-9995-BDAB869F01B3Q53126891-7AD3DDE0-0B15-4756-A425-B4AA7D2AD80A
P2860
Population pharmacokinetics and dose optimization of mycophenolic acid in HCT recipients receiving oral mycophenolate mofetil.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Population pharmacokinetics an ...... ng oral mycophenolate mofetil.
@ast
Population pharmacokinetics an ...... ng oral mycophenolate mofetil.
@en
type
label
Population pharmacokinetics an ...... ng oral mycophenolate mofetil.
@ast
Population pharmacokinetics an ...... ng oral mycophenolate mofetil.
@en
prefLabel
Population pharmacokinetics an ...... ng oral mycophenolate mofetil.
@ast
Population pharmacokinetics an ...... ng oral mycophenolate mofetil.
@en
P2093
P2860
P356
P1476
Population pharmacokinetics an ...... ng oral mycophenolate mofetil.
@en
P2093
P2860
P304
P356
10.1002/JCPH.14
P577
2013-02-04T00:00:00Z